| 发明名称 |
Tratamiento de enfermedades respiratorias |
| 摘要 |
A pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours. |
| 申请公布号 |
ES2266242(T5) |
申请公布日期 |
2016.10.04 |
| 申请号 |
ES20010966751T |
申请日期 |
2001.04.09 |
| 申请人 |
Sosei R&D Ltd. |
发明人 |
BANNISTER, Robin Mark;RICHARDS, Andrew John McGlashan;GILBERT, Julian Clive;MORTON, David A. V.;STANIFORTH, John |
| 分类号 |
A61K9/12;A61K9/72;A61K9/00;A61K9/14;A61K9/16;A61K31/00;A61K31/40;A61K31/4015;A61K31/46;A61K38/00;A61K45/00;A61K45/06;A61K47/12;A61K47/36;A61L9/04;A61P11/06;A61P11/08;A61P35/00;A61P43/00 |
主分类号 |
A61K9/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
